Takeda UK | Optimising the Management of ADHD in Adults
You are invited to join us and explore how to optimise the management of ADHD in adults. From untangling the diagnosis of ADHD in the presence of comorbid mental health conditions to delving into the psychopharmacology of ADHD medications and developing personalised treatment strategies, our eminent faculty will consider how to achieve optimal outcomes for adults with ADHD.
Hot topics such as substance use disorder, mood disorders and ADHD in women will also be covered and we will gain insights from a Canadian approach on how to optimally treat ADHD in adults.
Peer-to-peer sharing will be encouraged during these meetings. You have the option to attend virtually or in-person at our London event and in-person at our Manchester event.
Please REGISTER NOW to join our eminent faculty at one of these educational events.
Agenda: 12th March 2024 | Royal College of Physicians, 11 St. Andrew's Place, Regent's Park, London, NW1 4LE
Please note, both our in-person events are currently at max capacity. Please email lorna.oxford@takeda.com if you would like to be added to our waiting list.
| Time | Topic | Speakers |
|---|---|---|
| 09:30 - 10:00 | Registration | |
| 10:00 - 10:15 | Chairman's welcome & scene setting | Seyda Atadan-Memis (Takeda), Peter Mason, Allan Young |
| 10:15 - 10:45 | Differential diagnosis of ADHD and comorbid mental health disorders in adults | Mo Abdelghani |
| 10:45 - 11:15 | Individualising treatment strategies for adults with ADHD – sharing the Canadian experience | Don Duncan |
| 11:15 - 11:30 | Questions from delegates | |
| 11:30 - 12:00 | ADHD and substance use disorder – a dual diagnosis - new consensus statement and clinical implications | Peter Mason |
| 12:00 - 12:30 | Panel discussion and questions from delegates | |
| 12:30 - 13:15 | Lunch | |
| 13:15 - 16:15 | Delegates to be split into 3 workshop groups. Speakers will rotate between the groups, and there will be breaks between sessions. a) Back to basics: Psychopharmacology of ADHD medications – what’s the difference between them? b) Case studies: Optimal management of ADHD in adults with mood disorders c) Optimal management of ADHD in women |
a) David Nutt / Peter Mason b) Allan Young/ Mo Abdelghani c) Muffazal Rawala / Don Duncan |
| 16:15 - 16:45 | Clinical learnings from the breakout sessions – Ask the experts | |
| 16:45 - 17:00 | Closing comments | Peter Mason |
Agenda: 13th March 2024 | The Midland, 16 Peter Street, Manchester, M60 2DS
Please note, both our in-person events are currently at max capacity. Please email lorna.oxford@takeda.com if you would like to be added to our waiting list.
| Time | Topic | Speakers |
|---|---|---|
| 09:30 - 10:00 | Registration | |
| 10:00 - 10:15 | Welcome from Takeda, Chairman's welcome, & scene setting | Ashley Inglis (Takeda), Peter Mason |
| 10:15 - 10:45 | Differential diagnosis of ADHD and comorbid mental health disorders in adults | Joe Johnson |
| 10:45 - 11:15 | Individualising treatment strategies for adults with ADHD – sharing the Canadian experience | Don Duncan |
| 11:15 - 11:30 | Questions from delegates | |
| 11:30 - 12:00 | ADHD and substance use disorder – a dual diagnosis - new consensus statement and clinical implications | Peter Mason |
| 12:00 - 12:30 | Panel discussion and questions from delegates | |
| 12:30 - 13:15 | Lunch | |
| 13:15 - 16:15 | Delegates to be split into 3 workshop groups. Speakers will rotate between the groups, and there will be breaks between sessions. a) Back to basics: Psychopharmacology of ADHD medications – what’s the difference between them? b) Service development in practice (St. Helen’s example) c) Case studies:Optimal management of ADHD in women |
a) David Nutt / Peter Mason b) Shanmuga Prakash Natarajan / Joe Johnson c) Bhairavi Sapre / Don Duncan |
| 16:15 - 16:45 | Clinical learnings from the breakout sessions – Ask the experts | |
| 16:45 - 17:00 | Closing comments | Peter Mason |